Mutant t-PA with kringle replacement
    3.
    发明公开
    Mutant t-PA with kringle replacement 失效
    Muterter t-PA mit Kringle-Ersatz。

    公开(公告)号:EP0293934A1

    公开(公告)日:1988-12-07

    申请号:EP88108949.4

    申请日:1988-06-03

    摘要: Tissue plasminogen activator analogs exhibiting greater specificity for fibrin than native t-PA are disclosed. The analogs include the K1 domain of native t-PA replaced with another kringle domain mediating the binding of the analog to fibrin. The kringle contains six cysteine residues. The t-PA analogs may further include a variety of substitutions and modifications. Pharmaceutical compositions containing one or more of the t-PA analogs along with a physiologically acceptable carrier or diluent are also disclosed.

    摘要翻译: 公开了组织纤维蛋白溶酶原激活物类似物对纤维蛋白表现出比天然t-PA更强的特异性。 类似物包括天然t-PA的K1结构域被另一个介导类似物与纤维蛋白结合的三环结构域所取代。 三环含有六个半胱氨酸残基。 t-PA类似物还可以包括各种替代和修饰。 还公开了含有一种或多种t-PA类似物以及生理上可接受的载体或稀释剂的药物组合物。

    Process for purifying elastase
    7.
    发明公开
    Process for purifying elastase 失效
    一种纯化弹性蛋白酶的过程。

    公开(公告)号:EP0081831A2

    公开(公告)日:1983-06-22

    申请号:EP82111494.9

    申请日:1982-12-10

    申请人: Eisai Co., Ltd.

    IPC分类号: C12N9/66

    CPC分类号: C12N9/6448 Y10S435/814

    摘要: A process is disclosed for purifying elastase by precipitating elastase from an aqueous, elastasecontaining solution, in which the electroconductivity of said aqueous solution is adjusted to 3 millimhos per centimeter or less and the pH of the solution is adjusted to a value of from 2 to 5. The electroconductivity of said aqueous solution is preferably adjusted to 3 millimhos per centimeter or less by means of ultrafiltration.